Evidence map›Paper›PMID 27429547›Full record

ArticleGene regulation and systems biology2016

Community-Reviewed Biological Network Models for Toxicology and Drug Discovery Applications.

sbv IMPROVER project team and challenge best performers, Aishwarya Alex Namasivayam, Alejandro Ferreiro Morales, Ángela María Fajardo Lacave, Aravind Tallam, Borislav Simovic, David Garrido Alfaro, Dheeraj Reddy Bobbili, Florian Martin, Ganna Androsova and 20 more

Abstract read
In one paragraph

Article in Gene regulation and systems biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Bacteria and Allergic Diseases.International journal of molecular sciences · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Immunomodulatory and Allergenic Properties of Antimicrobial Peptides.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

sbv IMPROVER project team and challenge best performers
Aishwarya Alex NamasivayamLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Campus Belval, Esch-sur-Alzette, Luxembourg.
Alejandro Ferreiro MoralesPablo de Olavide University, Ctra. de Utrera, Seville, Spain.
Ángela María Fajardo LacavePablo de Olavide University, Ctra. de Utrera, Seville, Spain.
Aravind TallamTWINCORE, Zentrum für Experimentelle und Klinische Infektionsforschung, Hannover, Germany.
Borislav SimovicFM Pharm, Ltd., Sencanski put bb, Subotica, Serbia.
David Garrido AlfaroPablo de Olavide University, Ctra. de Utrera, Seville, Spain.
Dheeraj Reddy BobbiliLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Campus Belval, Esch-sur-Alzette, Luxembourg.
Florian MartinPhilip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud, Neuchâtel, Switzerland (part of Philip Morris International group of companies).
Ganna AndrosovaLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Campus Belval, Esch-sur-Alzette, Luxembourg.
Irina ShvydchenkoKuban State University of Physical Education, Sport and Tourism, Krasnodar, Russia.
Jennifer ParkSelventa, Alewife Center, Cambridge, MA, USA.
Jorge Val CalvoCenter for Molecular Biology, "Severo Ochoa" - Spanish National Research Council, Madrid, Spain.
Julia HoengPhilip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud, Neuchâtel, Switzerland (part of Philip Morris International group of companies).
Manuel C PeitschPhilip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud, Neuchâtel, Switzerland (part of Philip Morris International group of companies).
Manuel González Vélez RaceroPablo de Olavide University, Ctra. de Utrera, Seville, Spain.
Maria BiryukovLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Campus Belval, Esch-sur-Alzette, Luxembourg.
Marja TalikkaPhilip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud, Neuchâtel, Switzerland (part of Philip Morris International group of companies).
Modesto Berraquero PérezPablo de Olavide University, Ctra. de Utrera, Seville, Spain.
Neha RohatgiCenter for Systems Biology, University of Iceland, Reykjavik, Iceland.
Noberto Díaz-DíazPablo de Olavide University, Ctra. de Utrera, Seville, Spain.
Rajesh MandarapuPrakhya Research Laboratories, Lakshminagar, Selaiyur, Chennai, Tamil Nadu, India.
Rubén Amián RuizPablo de Olavide University, Ctra. de Utrera, Seville, Spain.
Sergey DavidyanInstitute of Biochemical Physics Russian Academy of Sciences, Moscow, Russia.
Shaman NarayanasamyLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Campus Belval, Esch-sur-Alzette, Luxembourg.
Stéphanie BouéPhilip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud, Neuchâtel, Switzerland (part of Philip Morris International group of companies).
Svetlana GuryanovaInstitute of Bioorganic Chemistry Russian Academy of Sciences, Moscow, Russia.
Susana Martínez ArbasLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Campus Belval, Esch-sur-Alzette, Luxembourg.
Swapna MenonAnalyzeDat Consulting Services, Edapally Byepass Junction, Kochi, Kerala, India.
Yang XiangPhilip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud, Neuchâtel, Switzerland (part of Philip Morris International group of companies).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biological network models offer a framework for understanding disease by describing the relationships between the mechanisms involved in the regulation of biological processes. Crowdsourcing can efficiently gather feedback from a wide audience with varying expertise. In the Network Verification Challenge, scientists verified and enhanced a set of 46 biological networks relevant to lung and chronic obstructive pulmonary disease. The networks were built using Biological Expression Language and contain detailed information for each node and edge, including supporting evidence from the literature. Network scoring of public transcriptomics data inferred perturbation of a subset of mechanisms and networks that matched the measured outcomes. These results, based on a computable network approach, can be used to identify novel mechanisms activated in disease, quantitatively compare different treatments and time points, and allow for assessment of data with low signal. These networks are periodically verified by the crowd to maintain an up-to-date suite of networks for toxicology and drug discovery applications.

Indexed as

biological networkCOPDcrowdsourcingdrug discoverytoxicology

Identifiers

PMID27429547
PMCPMC4944831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.